These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18364257)

  • 1. Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.
    Nakai R; Salisbury CM; Rosen H; Cravatt BF
    Bioorg Med Chem; 2009 Feb; 17(3):1101-8. PubMed ID: 18364257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries.
    Inglese J; Auld DS; Jadhav A; Johnson RL; Simeonov A; Yasgar A; Zheng W; Austin CP
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11473-8. PubMed ID: 16864780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extraction of structure-activity relationship information from high-throughput screening data.
    Wawer M; Bajorath J
    Curr Med Chem; 2009; 16(31):4049-57. PubMed ID: 19754425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.
    Lauer-Fields JL; Minond D; Chase PS; Baillargeon PE; Saldanha SA; Stawikowska R; Hodder P; Fields GB
    Bioorg Med Chem; 2009 Feb; 17(3):990-1005. PubMed ID: 18358729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragment-Based Discovery of 5-Arylisatin-Based Inhibitors of Matrix Metalloproteinases 2 and 13.
    Agamennone M; Belov DS; Laghezza A; Ivanov VN; Novoselov AM; Andreev IA; Ratmanova NK; Altieri A; Tortorella P; Kurkin AV
    ChemMedChem; 2016 Sep; 11(17):1892-8. PubMed ID: 27418256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technological advances in high-throughput screening.
    Liu B; Li S; Hu J
    Am J Pharmacogenomics; 2004; 4(4):263-76. PubMed ID: 15287820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual High-Throughput Screening for Matrix Metalloproteinase Inhibitors.
    Choi JY; Fuerst R
    Methods Mol Biol; 2017; 1579():259-271. PubMed ID: 28299742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of high throughput screening assays and pilot screen for inhibitors of metalloproteases meprin α and β.
    Madoux F; Tredup C; Spicer TP; Scampavia L; Chase PS; Hodder PS; Fields GB; Becker-Pauly C; Minond D
    Biopolymers; 2014 Sep; 102(5):396-406. PubMed ID: 25048711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods for computer-aided chemical biology. Part 5: rationalizing the selectivity of cathepsin inhibitors on the basis of molecular fragments and topological feature distributions.
    Ahmed HE; Bajorath J
    Chem Biol Drug Des; 2009 Aug; 74(2):129-41. PubMed ID: 19549075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design and optimization of pyrimidine- and 1,2,4-triazolo[4,3-a]pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology.
    El Ashry ESH; Awad LF; Teleb M; Ibrahim NA; Abu-Serie MM; Abd Al Moaty MN
    Bioorg Chem; 2020 Mar; 96():103616. PubMed ID: 32032847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitor fingerprinting of matrix metalloproteases using a combinatorial peptide hydroxamate library.
    Uttamchandani M; Wang J; Li J; Hu M; Sun H; Chen KY; Liu K; Yao SQ
    J Am Chem Soc; 2007 Jun; 129(25):7848-58. PubMed ID: 17539636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and evaluation of matrix metalloprotease inhibitors bearing cyclopropane-derived peptidomimetics as P1' and P2' replacements.
    Reichelt A; Gaul C; Frey RR; Kennedy A; Martin SF
    J Org Chem; 2002 Jun; 67(12):4062-75. PubMed ID: 12054939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput screening of metalloproteases using small molecule microarrays.
    Uttamchandani M
    Methods Mol Biol; 2010; 632():203-19. PubMed ID: 20217580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragment Linking and Optimization of Inhibitors of the Aspartic Protease Endothiapepsin: Fragment-Based Drug Design Facilitated by Dynamic Combinatorial Chemistry.
    Mondal M; Radeva N; Fanlo-Virgós H; Otto S; Klebe G; Hirsch AK
    Angew Chem Int Ed Engl; 2016 Aug; 55(32):9422-6. PubMed ID: 27400756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel miniaturized systems in high-throughput screening.
    Battersby BJ; Trau M
    Trends Biotechnol; 2002 Apr; 20(4):167-73. PubMed ID: 11906749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer and virus leads by HTS, chemical design and SEA data mining.
    Thepchatri P; Min J; Ganesh T; Du Y; Lewis I; Kurtkaya S; Prussia A; Li L; Sneed B; Plemper RK; Fu H; Liotta DC; Snyder JP; Dingledine R; Sun A
    Curr Top Med Chem; 2009; 9(13):1159-71. PubMed ID: 19807668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which aspects of HTS are empirically correlated with downstream success?
    Bender A; Bojanic D; Davies JW; Crisman TJ; Mikhailov D; Scheiber J; Jenkins JL; Deng Z; Hill WA; Popov M; Jacoby E; Glick M
    Curr Opin Drug Discov Devel; 2008 May; 11(3):327-37. PubMed ID: 18428086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hit-directed nearest-neighbor searching.
    Shanmugasundaram V; Maggiora GM; Lajiness MS
    J Med Chem; 2005 Jan; 48(1):240-8. PubMed ID: 15634017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fragment screening: an introduction.
    Leach AR; Hann MM; Burrows JN; Griffen EJ
    Mol Biosyst; 2006 Sep; 2(9):430-46. PubMed ID: 17153140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.